Computational Infrastructure for Modern Pharmaceuticals

Explaining Digital-Robotic Technology for Pharmaceutical R&D

Add bookmark

Computational Infrastructure for Modern Pharmaceuticals

We respect your privacy, by clicking "Download Your Copy" you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.

Over the last 150 years, the pharmaceutical industry has gone through different phases of transformation.

Every phase incorporated new technologies of the time: Synthetic chemistry in the late 19th century, molecular biology after WWII, and bioengineering in the late 20th century. In the last few years, we have been observing the beginning of another leap that is incorporating advanced computing technology and robotic automation. The word modern in the title refers to another phase of modernization.

This paper, authored by Alireza Shabani, Founder & CEO of Qulab, describes the necessary computational architecture for pharmaceutical firms to accelerate R&D and drug discovery, especially utilizing special purpose silicon and quantum processors.

Read the paper to learn about:

  • A New Computing Frontier for Pharma R&D
  • Application-Specific Integrated Circuits
  • Quantum Computers
  • Digitization and automation for Pharma R&D

Hear more from Qulab, and the future of quantum-enabled pharma at Quantum.Tech, September 10-11 2019, at the Sheraton Boston.

The global business conference & exhibition for commercial applications of Quantum technology


Download THE PAPER now